Presentation TCT 2017 The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation - Are the Results Enough to Change Practice? Presenter: C. Michael Gibson November 01, 2017 REGISTER for free or LOG IN to view this content Coronary Presentation TCT 2017 CAD Pharma Up Next Presentation TCT 2017 The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation - How to Incorporate the Results in Clinical Practice Presenter: Deepak L. Bhatt November 01, 2017 More slides + Presentation TCT 2017 The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI - Design, Rationale, and Status Presenter: Renato D. Lopes November 01, 2017 Presentation TCT 2017 The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status Presenter: Pascal Vranckx November 01, 2017 We Recommend
Presentation TCT 2017 The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation - How to Incorporate the Results in Clinical Practice Presenter: Deepak L. Bhatt November 01, 2017
Presentation TCT 2017 The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI - Design, Rationale, and Status Presenter: Renato D. Lopes November 01, 2017
Presentation TCT 2017 The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status Presenter: Pascal Vranckx November 01, 2017